This information collection supports
FDA regulations governing recalls. The information collection
provisions apply to all regulated products (i.e., food, including
animal feed; drugs, including animal drugs; medical devices,
including in vitro diagnostic products; cosmetics; biological
products intended for human use; and tobacco). Respondents to the
collection are those who introduce FDA-regulated products into
interstate commerce or who are otherwise subject to the applicable
regulations.
The adjustment in burden is due
to the decreased number of respondents from 3,801 to 2,853 (-948).
FDA discovered that 21 CFR 7.59 (general industry guidance)
contained information collection that was not previously approved
and, therefore, added it to this ICR request for extension of OMB
approval. Despite this addition the estimated total burden has
decreased 137,409 hours.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.